Bradley G. Somer, MD, is a nationally-recognized expert in cancer care. His passion is his patients and their families.
Titles and Roles
- Medical Oncologist, West Cancer Center
- Senior Partner, Executive Cancer Council, West Cancer Center
- Associate Professor, Department of Hematology and Medical Oncology, University of Tennessee Health Science Center
- Head of Strategic Expansion/Development, West Cancer Center Research Program
Areas of Expertise
- Gastrointestinal cancers
- Genitourinary cancers
- Breast cancer
- Lung cancer
Dr. Somer is a senior partner at West Cancer Center and is part of the leadership team. Dr. Somer joined the West team in 2002 after completing his fellowship training at the University of Pennsylvania Cancer Center. Dr. Somer also completed his internship and residency at the Hospital University of Pennsylvania in Philadelphia. Board Certified in Medical Oncology, he sees patients in our Memphis, TN, and Southaven, MS, offices. Dr. Somer is actively involved in clinical research, often participating as principal investigator in research trials at West Cancer Center. “Our clinical trial offerings exceed many top academic programs across the country where people travel long distances to seek medical care. It is a crown jewel for the Memphis cancer community for patients to have access to potential treatments long before they reach the general community.”
Dr. Somer chairs the Committee on Cancer for Methodist LeBonheur Healthcare system. He has served on the board of Community Oncology Alliance. He serves on the board of the UT/West Institute for Cancer Research, and leads several strategic initiatives, major projects and committees as part of West Cancer Center. Dr. Somer is married with 5 children. He devotes the majority of his spare time to family and community leadership activities.
Education and Training
Dr. Somer graduated from Albert Einstein College of Medicine with the top award at graduation in “outstanding Scholarship, devotion to patient care, and concern for colleagues”. He was elected to the Alpha Omega Alpha medical honors society. He did his internship and residency at the Hospital of University of Pennsylvania and his fellowship at the University of Pennsylvania Cancer Center.
- Leukemia-Lymphoma Society- Man of the Year Award, Mid-South, 2002-2003
- Alpha Omega Alpha, 1996
- Edward Weinstein Memorial Award for Outstanding Scholarship. Devotion To Patient Care, and Concern For Colleagues, 1996
Dr. Somer’s current and recent research projects include:
- Investigating novel anti-androgen agents in pre-metastatic castrate resistant prostate cancer, and combination treatments in metastatic prostate cancer
- Novel cancer vaccines for use in prostate cancer
- Immune checkpoint inhibitors for bladder cancer and renal cancer
- Various molecular targeted therapy for bladder, renal and prostate cancer
- Novel combination therapy for metastatic colorectal cancer
- Combination of standard chemotherapy with novel immunotherapy for pancreatic cancer
- Various molecular targeted agents and immune checkpoint inhibitors for colorectal, gastric, pancreas, hepatobiliary cancers
Most recently, Dr. Somer has been published several times, including articles on treatment patterns and clinical effectiveness in metastatic castrate resistant prostate cancer, renal cell carcinoma, novel therapies in pancreatic cancer, combination chemotherapy in colorectal cancer.
To view Dr. Somer’s most recent publications, click here.